The inhibitory effects of 5-hydroxy-3,6,7,8,3′,4′-hexamethoxyflavone on human colon cancer cells

Targeting NF-κB for colorectal cancer

(2010) Kei Sakamoto et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Colon carcinogenesis: Learning from NF-κB and AP-1

(2010) Aristides G. Vaiopoulos et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

The p53-, Bax- and p21-dependent inhibition of colon cancer cell growth by 5-hydroxy polymethoxyflavones

(2010) Peiju Qiu et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Inhibitory effects of 5-hydroxy polymethoxyflavones on colon cancer cells

(2010) Peiju Qiu et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Understanding resistance to EGFR inhibitors—impact on future treatment strategies

(2010) Deric L. Wheeler et al.   Nature Reviews Clinical Oncology

Molecular markers and targets for colorectal cancer prevention

(2009) Naveena B Janakiram et al.   ACTA PHARMACOLOGICA SINICA

NFκB signaling in carcinogenesis and as a potential molecular target for cancer therapy

(2009) Han-Ming Shen et al.   APOPTOSIS

Assessment of K-rasmutation

(2009) Yixing Jiang et al.   CANCER

Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer

(2009) Eric Van Cutsem et al.   NEW ENGLAND JOURNAL OF MEDICINE

Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer

(2008) Rafael G. Amado et al.   JOURNAL OF CLINICAL ONCOLOGY

Monodemethylated polymethoxyflavones from sweet orange (Citrus sinensis) peel Inhibit growth of human lung cancer cells by apoptosis

(2008) Hang Xiao et al.   MOLECULAR NUTRITION & FOOD RESEARCH

K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer

(2008) Christos S. Karapetis et al.   NEW ENGLAND JOURNAL OF MEDICINE